Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Procter & Gamble Company    PG

PROCTER & GAMBLE COMPANY

(PG)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

P&G Adds To Streak Of Sales Increases -- WSJ

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/23/2019 | 02:47am EST

By Sharon Terlep

Procter & Gamble Co. posted another quarter of strong sales of household staples and said it was well positioned to ride out any pullback in consumer spending.

Helped by price increases, the maker of Tide laundry detergent and Pampers diapers said revenue rose across all of its business lines, including its beleaguered Gillette shaving unit. P&G is now growing at a faster pace than competitors such as Unilever PLC and Kimberly-Clark Corp.

The Cincinnati company said organic sales, a measure that excludes currency moves and deals, rose 7% from a year ago. Kimberly-Clark, maker of Huggies diapers and Kleenex tissues, on Tuesday said organic sales rose 4%. Unilever, with brands including Dove soap, last week reported organic sales growth of 2.9%

P&G's growth sputtered in the years following the 2008 financial crisis and only last year returned to levels seen before the economy soured. Its turnaround has been driven by higher prices, new products and a leaner portfolio of brands.

"We are better positioned now than in 2008 to handle a downturn," P&G finance chief Jon Moeller said Tuesday in a call with analysts who questioned whether the company's results would hold up should consumers curtail spending. He said the company sees "no signs of weakness, but that can change."

Economies have been slowing around the globe recently. Household spending in the U.S. ticked up 0.1% on a seasonally adjusted basis in August compared with July, lower than the average gains during the first seven months of the year. Last week, the International Monetary Fund cut its forecast for global economic growth this year to 3%.

Mr. Moeller said P&G has largely stopped selling products that tend to suffer amid consumer belt-tightening, such as makeup and perfume. Instead, the company has focused on developing pricier offerings in essential products such as laundry soap and toothpaste.

Consumers' willingness to pay higher prices for household staples, with increases driven largely by P&G as the industry's biggest player, has fueled the company's growth. This summer, P&G reported its strongest fiscal year since before the recession. It was a marked reversal from the previous year, when P&G was lagging rivals and the company was growing 1% to 2% a quarter. Activist investor Nelson Peltz joined P&G's board the spring of 2018 following the most expensive proxy contest in history.

Consumer-products executives have said they expect higher pricing to abate in coming quarters. That has already begun to happen in some areas. Pricing accounted for 1% of P&G's sales gains in the most recent quarter, compared with a 3% contribution the previous quarter.

P&G is betting that shoppers will nonetheless continue to favor higher-end variations, such as specialty toothpaste, adult diapers made to resemble lingerie and laundry scent-beads designed to make loads more fragrant.

If they don't, Mr. Moeller said, P&G believes it can continue to drive sales gains by offering items packaged in smaller quantities and with marketing aimed at budget-conscious consumers. "If there is a downturn, we're as best positioned for consumers who are in a pinch," he said.

P&G's net sales were $17.8 billion for the quarter ended Sept. 30; net earnings rose to $3.6 billion, from $3.2 billion a year earlier. The company notched its best sales gains in its beauty segment, where organic sales increased 10% in part on higher demand for P&G's skin care products in China, namely its high-end SK-II brand.

Organic sales in the company's health care segment rose 9%. Mr. Moeller said the unit was buoyed by brands acquired in last year's $4.2 billion purchase of the consumer-health business from Germany's Merck KGaA, which added vitamins and food supplements to its lineup of over-the-counter medicines.

Kimberly-Clark said higher prices largely drove the company's latest quarterly sales increase. CEO Michael Hsu said the company, like P&G, is betting that shoppers will continue to favor premium products, such as a line of Huggies diapers launched this year that costs roughly 40% more than the priciest offering previously on the market.

"Premiumization is the path a company like ours needs to take," Mr. Hsu said Tuesday on a call with analysts.

Both P&G and Kimberly-Clark raised their full-year forecasts.

--Micah Maidenberg contributed to this article

Write to Sharon Terlep at sharon.terlep@wsj.com

Stocks mentioned in the article
ChangeLast1st jan.
KIMBERLY-CLARK CORPORATION 0.01% 135.94 Delayed Quote.19.31%
MERCK AND COMPANY 0.26% 89.19 Delayed Quote.16.73%
MERCK KGAA -0.10% 102.7 Delayed Quote.14.14%
MERCK LTD 0.10% 4136.95 End-of-day quote.31.33%
PROCTER & GAMBLE COMPANY 0.72% 125.47 Delayed Quote.36.50%
THE WENDY'S COMPANY 1.51% 21.835 Delayed Quote.39.88%
UNILEVER N.V. 0.76% 54.18 Delayed Quote.14.30%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on PROCTER & GAMBLE COMPANY
12/12Amneal Shares Up Nearly 50% on FDA Nod for NuvaRing Generic
DJ
12/11PROCTER & GAMBLE : P&G 2019 Citizenship Report Highlights Commitment to Communit..
AQ
12/10Trucking Market Will Absorb Celadon Shutdown, Transport Experts Say
DJ
12/10Merck, Sanofi Push To Add Cancer Drugs -- WSJ
DJ
12/10Brands Find Store Shelves Still Matter -- WSJ
DJ
12/09NEWS HIGHLIGHTS : Top Company News of the Day
DJ
12/09Big Brands, Online Startups Find Success Rests on Store Shelves -- Update
DJ
12/09Health Care Down Amid Mixed Reactions To Cancer-Drug Acquisitions -- Health C..
DJ
12/09Wall Street falls as health shares drag
RE
12/09Big Drugmakers Push Deeper Into Cancer Treatment -- 3rd Update
DJ
More news
Financials (USD)
Sales 2020 70 583 M
EBIT 2020 15 605 M
Net income 2020 12 825 M
Debt 2020 20 920 M
Yield 2020 2,39%
P/E ratio 2020 25,7x
P/E ratio 2021 24,0x
EV / Sales2020 4,73x
EV / Sales2021 4,57x
Capitalization 313 B
Chart PROCTER & GAMBLE COMPANY
Duration : Period :
Procter & Gamble Company Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PROCTER & GAMBLE COMPANY
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Average target price 128,38  $
Last Close Price 125,47  $
Spread / Highest target 11,6%
Spread / Average Target 2,32%
Spread / Lowest Target -15,5%
EPS Revisions
Managers
NameTitle
David S. Taylor Chairman, President & Chief Executive Officer
Jon R. Moeller Vice Chairman, Chief Operating & Financial Officer
Kathleen B. Fish Chief Research, Development & Innovation Officer
Javier Polit Chief Information Officer
Scott D. Cook Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
PROCTER & GAMBLE COMPANY36.50%312 899
UNILEVER N.V.14.30%142 133
THE ESTÉE LAUDER COMPANIES INC.56.20%73 118
HINDUSTAN UNILEVER LTD11.53%61 304
COLGATE-PALMOLIVE COMPANY12.95%58 870
RECKITT BENCKISER GROUP PLC0.40%57 122